SlideShare a Scribd company logo
Medical devices (IVD) – application process
Session Chair ―
Wendy-Jane Morrow
Chief Executive Officer, IVD Australia
Speakers / Panelists ―
Euan Miller
Assistant Director, Therapeutic Goods Administration
Chris Harwood
Assistant Director, Therapeutic Goods Administration
Karen MacLeod
Business Manager, Diagnostics, MP Biomedicals Australasia Pty Ltd
Medical Devices (IVDs)
Applications for ARTG inclusion
Euan Miller
Application and Verification Section
Medical Devices Branch
Devices Sponsor Information Day
15 October 2015
Purpose
Facilitate better understanding of the
regulatory requirements for IVD medical
devices
ARTG inclusion – explain the process
and give some examples
What is a medical device?
• Used for human beings
• Intended purpose
– Diagnose, prevent, monitor, treat or alleviate disease or compensate for injury or
disability
– Investigation, replacement or modification of anatomy or physiological processes
– Control conception
– Accessory to a medical device as described above
• Is to be ascertained from the information provided on or in any one or
more of the following:
- Labelling
- Instructions for use
- Any manufacturer’s advertising material relating to the product
- Technical documentation
Therapeutic Goods Act 1989, section 41BD
In vitro diagnostic (IVD) medical device
• A reagent, calibrator, control material, kit, specimen receptacle,
instrument, software, equipment or system
• Intended for the in vitro examination of human specimens for
- giving information about a physiological or pathological state
- giving information about a congenital abnormality
- determining safety and compatibility with a potential recipient
- monitoring therapeutic measures
Dictionary, Therapeutic Goods (Medical Devices) Regulations 2002
Examples
Types of IVD medical devices
• Intended to be used by:
– health professionals in the laboratory
– health professionals at the point of
care
– lay-person (self-testing)
• Does not include Research Use Only
(RUO) or Analyte Specific Reagents
(ASR)
ARTG inclusion
• Any IVD medical device must be included in ARTG
- Transitional provisions ended on 30 June 2015
• Except:
- Devices for which effective applications for inclusion in
the ARTG were submitted before the end of transitional
period but not yet finalised
- In-house IVD medical devices (transitional provisions
until 30 June 2017)
• Sponsor is responsible for ARTG inclusion
Before you start
• TGA Business Services (TBS)
- Register and get your Client ID
Important
Classification based on the intended purpose
and level of risk of the device
Conformity assessment procedures
Essential principles for safety and performance
Post-market monitoring
Process for ARTG inclusion
Manufacturer Evidence
• Manufacturer must apply appropriate conformity assessment
procedure to the device (quality management system and control
over the design of the device)
• Sponsor must lodge the manufacturer’s certification of the conformity
assessment with the TGA
- Except for Class 1 IVD
Acceptable certificates
- TGA conformity assessment certificate
- EC Certificate issued in accordance with IVDD 98/79/EC
- ISO 13485 (CMDCAS ISO 13485 or IAF ISO 13485)
Manufacturer Evidence
 ACCEPTED
−What does it mean?
Go to the next step - lodging application
for ARTG inclusion
Application for ARTG inclusion
• Must be made for a kind of device and
• Must be effective
- Made in accordance with a form and manner
approved (via TBS)
- Application fee is paid
- For Class 4 IVD – conformity assessment certificate
must be issued by the TGA for the device
- Must not contain information that is false or
misleading in a material particular
Matters certified must be correct
medical device
intended purpose
correctly classified
essential principles and availability of information to substantiate compliance
application of conformity assessment procedure and availability of information
requirements (if any) relating to advertising
prohibited imports
excluded purposes
information in or with the application is complete and correct
Therapeutic Goods Act 1989, section 41FD
Common questions
Kind of device
Intended purpose
Classification
Conformity assessment procedure
GMDN code
Kind of device
• Sponsor
• Manufacturer
• Device nomenclature system code
(GMDN)
• Classification
• Unique product identifier
(for Class 4 IVDs)
a medical device
is taken to be of
the same kind as
another medical
device if they
have the same:
Therapeutic Goods Act 1989, section 41BE and Therapeutic Goods (Medical
Devices) Regulations 2002, regulations 1.6 and 1.7
Examples of the kinds of devices
• Blood glucose monitoring system (BGMS) (including
strips) AND test strips AND controls
 These devices are of the same kind
• BGMS (excluding strips) AND test strips AND controls
X These devices are not of the same kind
Intended purpose of a kind of device
• Means the purpose for which the manufacturer of the
device intends it to be used, as stated in the information
provided with the device (labeling, instructions for use,
advertising material and technical documentation)
• Intended purpose stated in the application must be
consistent with the purpose for which the manufacturer
intends the devices of the kind to be used
- specific versus general
- 500 characters only (in the application)
IVD medical devices are classified having
regard to the intended purpose of the device
and its risk to public health and/or personal risk
RISK
• Class 1 IVD – no public health risk or low
personal risk
• Class 2 IVD – low public health risk or moderate
personal risk
• Class 3 IVD – moderate public health risk or
high personal risk
• Class 4 IVD – high public health risk
Therapeutic Goods (Medical Devices) Regulations 2002, division 3.1 and schedule 2A
Classification (Schedule 2A)
Rule 1.1
Class 4
Rule 1.2
Class 3 /4
Rule 1.3
Class 3
Rule 1.4
self-
testing
Rule 1.5
QC
Rule 1.6
Class 1
Rule 1.7
Class 2
Rule 1.8
Class 1
Export
only
Classification examples
• Class 1 IVDs
- Microbiological culture media;
instruments/analysers
• Class 2 IVDs
- Pregnancy self-tests, H&E stain
• Class 3 IVDs
- sexually transmitted diseases; genetic tests
(inc. FISH)
• Class 4 IVDs
- screen blood donors for HIV & HCV; ABO
Common questions
• Pathogens listed on the Australian National Notifiable
Disease Surveillance System (NNDSS) list
• Human genetic testing
• Patient selection* for:
i. selective therapy and management
ii. disease staging
iii. diagnosis of cancer
*An IVD medical device would fall into Class 2 IVD if
a) a therapy decision would usually be made only after further
investigation; or
b) the device is used for monitoring
Conformity assessment procedure
Declaration of conformity
- To be provided with the application:
 Class 3 IVDs
- Must be made in accordance with Schedule 3 of the
Therapeutic Goods (Medical Devices) Regulations 2002
- Must contain correct information (including Certificate
number appropriate for the device)
- Templates available
Global Medical Device Nomenclature (GMDN)
• GMDN code
- one of the characteristics that defines the kind of device
- is to be consistent with the intended purpose of the device
• Depends on Class of IVD device
- relevant preferred term or
- Level 1, Level 2 or Level 3 collective term (CT)
Manufacturer’s responsibility
GMDN examples
IVD medical device GMDN
HIV1/HIV2 antigen IVD, kit,
immunochromatographic test (ICT) rapid
[30832]
Human immunodeficiency viruses (HIV) [CT284]
Viral Infectious disease IVDs [CT355]
Infectious disease IVDs [CT701]
GMDN – more examples
IVD medical device GMDN
Multiple urine analyte IVD, kit, colourimetric
dipstick, rapid
[30225]
Urine screening IVDs [CT1246]
Clinical chemistry biological screening IVDs [CT1236]
Clinical chemistry IVDs [CT287]
GMDN – one more example
IVD medical device GMDN
Glucose monitoring system IVD, home
use/point-of-care
[30854]
No relevant level 3 Collective Term (CT)
Clinical chemistry substrate IVDs [CT833]
Clinical chemistry IVDs [CT287]
IVD Name and Category
For any type of IVD device referred to in Regulation
5.3(1)(j), the application form requires applicants to enter
the names of all individual devices of the kind as these
devices appear on the labelling.
Procedure Packs containing IVD
• Goods in the package are a system or procedure pack if
- the goods are for use as a unit, either in combination or
in a medical or surgical procedure and
- the package contains at least one medical device
• Classification
- is determined by the highest class of device included in
the pack or
- if all devices are of the same class, it is classified
according to the primary intended purpose of the system
or procedure pack
Procedure packs
Reg. 3.3 (9) – highest classification
IVD
(Class 3)
MD
(Class IIa)
Class 3
IVD
Procedure
Pack
Procedure packs
Reg. 3.3 (10) same class
IVD
(Class 1)
MD
(Class I)
Class 1 IVD
or Class I
MD
Procedure
Pack
Intended purpose
One kind of device
Supplied as a SINGLE
unit
Instrument
Control/CalibratorsAssay Kit
Devices are not of the same kind
System
Instrument
(Class 1 IVD)
Controls /
Calibrators
Assay Kit
Accessories
Where do we go from here?
Ensure all information
provided in the
application is correct
Any application may be
selected for audit
Some applications must be selected for
audit
Further information
• IVD medical devices regulation basics
• News, consultations, guidance, subscribe to updates
TGA website
• Therapeutic Goods Act 1989, Chapter 4
• Therapeutic Goods (Medical Devices) Regulations 2002
ComLaw: Database of Commonwealth law
• devices@tga.gov.au 1800 141 144
Contact the TGA Medical Devices Branch
The Application Process
• Introduction
• This presentation will step through the process of making an
application for inclusion on the ARTG
• The format is screen shots highlighting the key steps
• Two scenarios will be presented
• An uncomplicated Class2 IVD
• A Class 3 IVD requiring higher level scrutiny
The Application Process
• Before you start
• The appropriate Manufacturer’s Evidence for your IVD must be
submitted and accepted.
• Know the Class of your IVD.
• Know the GMDN term for your IVD.
• Have at hand any other evidence that will be required, such as
• Declaration of Conformity (for all Class 3)
• Design Examination Certificate (for all Class 4)
https://business.tga.gov.au
Your company name and number
Navigation buttons top and bottom
on each page
Free text
The Application Process
Scenario 1
• Class 2
• Manufacturer Evidence CMDCAS ISO 13485 Certificate
• “No” to device product characteristics questions
The Application Process
Scenario 2
• Class 3
• Manufacturer Evidence TGA Conformity Assessment Certificate
• “Yes” to device product characteristics questions
• Testing for a sexually transmitted agent
TGA Conformity Assessment Certificate = the application is
unlikely to be selected for audit
The Application Process
GMDN selection
• The same for either scenario
The Application Process
Finalisation
Class 2
• Make the declaration, Validate
and submit
The Application Process
Finalisation
Class 3
• Declaration of Conformity to be
attached
Questions?
Brought to you by:

More Related Content

What's hot

The regulation of medical devices in Australia
The regulation of medical devices in AustraliaThe regulation of medical devices in Australia
The regulation of medical devices in Australia
TGA Australia
 
Devices Sponsor Information Day: 1 - Conformity Assessment
Devices Sponsor Information Day: 1 - Conformity AssessmentDevices Sponsor Information Day: 1 - Conformity Assessment
Devices Sponsor Information Day: 1 - Conformity Assessment
TGA Australia
 
Medical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing SurvellianceMedical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing Survelliance
CSIR-URDIP, NCL Campus, Pune
 
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
TGA Australia
 
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessmentsDevices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
TGA Australia
 
Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...
Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...
Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...
TGA Australia
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in US
Ankit Geete
 
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
TGA Australia
 
Medical devices
Medical devicesMedical devices
Medical devices
Tarun Kumar Reddy
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
ulmedical
 
China\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessChina\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory Process
MedTech Review, LLC
 
Specially know how to determine the classification of medical devices in china
Specially know how to determine the classification of medical devices in chinaSpecially know how to determine the classification of medical devices in china
Specially know how to determine the classification of medical devices in china
CIRS China
 
Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...
Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...
Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...NAMSA
 
medical device regulatory approval in USA
medical device regulatory approval in USAmedical device regulatory approval in USA
medical device regulatory approval in USA
Suraj Pamadi
 
China: Medical Device Regulations
China: Medical Device RegulationsChina: Medical Device Regulations
China: Medical Device Regulations
Pacific Bridge Medical
 
Medical device management in china and latest regulatory updates_Edwin
Medical device management in china and latest regulatory updates_EdwinMedical device management in china and latest regulatory updates_Edwin
Medical device management in china and latest regulatory updates_Edwin
CIRS China
 
Medical device regulation US, European Union and India
Medical device regulation  US, European Union and IndiaMedical device regulation  US, European Union and India
Medical device regulation US, European Union and India
CSIR-URDIP, NCL Campus, Pune
 
mHealth Summit EU 2015
mHealth Summit EU 2015mHealth Summit EU 2015
mHealth Summit EU 2015
3GDR
 
FDA regulation for medical devices
FDA regulation for medical devicesFDA regulation for medical devices
FDA regulation for medical devices
Simrana Fathima
 
The Regulation Of Medical Device In China
The Regulation Of Medical Device In ChinaThe Regulation Of Medical Device In China
The Regulation Of Medical Device In China
Jacobe2008
 

What's hot (20)

The regulation of medical devices in Australia
The regulation of medical devices in AustraliaThe regulation of medical devices in Australia
The regulation of medical devices in Australia
 
Devices Sponsor Information Day: 1 - Conformity Assessment
Devices Sponsor Information Day: 1 - Conformity AssessmentDevices Sponsor Information Day: 1 - Conformity Assessment
Devices Sponsor Information Day: 1 - Conformity Assessment
 
Medical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing SurvellianceMedical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing Survelliance
 
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
 
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessmentsDevices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
 
Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...
Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...
Device Sponsor Information Day: Session 2: Clinical evidence - pre-market and...
 
Regulation of Medical Devices in US
Regulation of Medical Devices in USRegulation of Medical Devices in US
Regulation of Medical Devices in US
 
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
 
Medical devices
Medical devicesMedical devices
Medical devices
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
 
China\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessChina\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory Process
 
Specially know how to determine the classification of medical devices in china
Specially know how to determine the classification of medical devices in chinaSpecially know how to determine the classification of medical devices in china
Specially know how to determine the classification of medical devices in china
 
Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...
Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...
Chinese Food and Drug Administration (CFDA) Regulatory Approval Process: Medi...
 
medical device regulatory approval in USA
medical device regulatory approval in USAmedical device regulatory approval in USA
medical device regulatory approval in USA
 
China: Medical Device Regulations
China: Medical Device RegulationsChina: Medical Device Regulations
China: Medical Device Regulations
 
Medical device management in china and latest regulatory updates_Edwin
Medical device management in china and latest regulatory updates_EdwinMedical device management in china and latest regulatory updates_Edwin
Medical device management in china and latest regulatory updates_Edwin
 
Medical device regulation US, European Union and India
Medical device regulation  US, European Union and IndiaMedical device regulation  US, European Union and India
Medical device regulation US, European Union and India
 
mHealth Summit EU 2015
mHealth Summit EU 2015mHealth Summit EU 2015
mHealth Summit EU 2015
 
FDA regulation for medical devices
FDA regulation for medical devicesFDA regulation for medical devices
FDA regulation for medical devices
 
The Regulation Of Medical Device In China
The Regulation Of Medical Device In ChinaThe Regulation Of Medical Device In China
The Regulation Of Medical Device In China
 

Viewers also liked

UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...
UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...
UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...
ulmedical
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
TGA Australia
 
FDA Focus on Design Controls
FDA Focus on Design Controls FDA Focus on Design Controls
FDA Focus on Design Controls
April Bright
 
FDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic testsFDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic tests
MaRS Discovery District
 
Strategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and AustraliaStrategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and Australia
April Bright
 
Steps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device RegulationsSteps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device Regulations
April Bright
 
CAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward ClosureCAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward Closure
April Bright
 
How to Implement ISO 13485 Updates
How to Implement ISO 13485 UpdatesHow to Implement ISO 13485 Updates
How to Implement ISO 13485 Updates
April Bright
 
ISO 13485:2016 Revisions Webinar
ISO 13485:2016 Revisions WebinarISO 13485:2016 Revisions Webinar
ISO 13485:2016 Revisions Webinar
DQS Inc.
 
Presentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflectionPresentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflection
TGA Australia
 

Viewers also liked (10)

UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...
UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...
UL Webinar - Updates to the Regulatory Framework in Korea and their impact to...
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
 
FDA Focus on Design Controls
FDA Focus on Design Controls FDA Focus on Design Controls
FDA Focus on Design Controls
 
FDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic testsFDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic tests
 
Strategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and AustraliaStrategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and Australia
 
Steps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device RegulationsSteps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device Regulations
 
CAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward ClosureCAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward Closure
 
How to Implement ISO 13485 Updates
How to Implement ISO 13485 UpdatesHow to Implement ISO 13485 Updates
How to Implement ISO 13485 Updates
 
ISO 13485:2016 Revisions Webinar
ISO 13485:2016 Revisions WebinarISO 13485:2016 Revisions Webinar
ISO 13485:2016 Revisions Webinar
 
Presentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflectionPresentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflection
 

Similar to Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for ARTG inclusion

TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Australia
 
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
TGA Australia
 
TGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessmentsTGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessments
TGA Australia
 
Lancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshopLancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshop
Innovation Agency
 
EU MDD.pptx
EU MDD.pptxEU MDD.pptx
EU MDD.pptx
AartiVats5
 
Future of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics RegulationFuture of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics Regulation
Erik Vollebregt
 
Medical devices-pre-market-authorisation
Medical devices-pre-market-authorisationMedical devices-pre-market-authorisation
Medical devices-pre-market-authorisation
TGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Australia
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
TGA Australia
 
Medical Device Regulatory Approval
Medical Device Regulatory ApprovalMedical Device Regulatory Approval
Medical Device Regulatory Approvalruyang89
 
MHRA - 18th March 2014
MHRA - 18th March 2014MHRA - 18th March 2014
MHRA - 18th March 2014
Anthony A Hill
 
Advamed MDR IVDR update
Advamed MDR IVDR updateAdvamed MDR IVDR update
Advamed MDR IVDR update
Erik Vollebregt
 
STED
STEDSTED
Presentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices BranchPresentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices Branch
TGA Australia
 
EU MDR
EU MDR EU MDR
EU MDR
RohitParkale
 
Medical devices
Medical devicesMedical devices
Medical devices
Somnath Zambare
 
Regulation of medical device in japan
Regulation of medical device in japanRegulation of medical device in japan
Regulation of medical device in japan
KrushnaAgnihotri
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulation
TGA Australia
 
TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...
TGA Australia
 
MDD 93/42/EEC
MDD 93/42/EECMDD 93/42/EEC
MDD 93/42/EEC
Pavan Kumar Malwade
 

Similar to Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for ARTG inclusion (20)

TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
TGA Presentation: Medical Devices - Manufacturer Evidence and applications fo...
 
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
Sponsor Information and Training day Session C1 - IVDs: eBS applications and ...
 
TGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessmentsTGA presentation: medical devices audit assessments
TGA presentation: medical devices audit assessments
 
Lancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshopLancashire SME workshop - regulation and medical device workshop
Lancashire SME workshop - regulation and medical device workshop
 
EU MDD.pptx
EU MDD.pptxEU MDD.pptx
EU MDD.pptx
 
Future of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics RegulationFuture of EU In Vitro Diagnostics Regulation
Future of EU In Vitro Diagnostics Regulation
 
Medical devices-pre-market-authorisation
Medical devices-pre-market-authorisationMedical devices-pre-market-authorisation
Medical devices-pre-market-authorisation
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Medical Device Regulatory Approval
Medical Device Regulatory ApprovalMedical Device Regulatory Approval
Medical Device Regulatory Approval
 
MHRA - 18th March 2014
MHRA - 18th March 2014MHRA - 18th March 2014
MHRA - 18th March 2014
 
Advamed MDR IVDR update
Advamed MDR IVDR updateAdvamed MDR IVDR update
Advamed MDR IVDR update
 
STED
STEDSTED
STED
 
Presentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices BranchPresentation: Update from the Medical Devices Branch
Presentation: Update from the Medical Devices Branch
 
EU MDR
EU MDR EU MDR
EU MDR
 
Medical devices
Medical devicesMedical devices
Medical devices
 
Regulation of medical device in japan
Regulation of medical device in japanRegulation of medical device in japan
Regulation of medical device in japan
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulation
 
TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...TGA webinar presentation: Regulation of software, including software as a med...
TGA webinar presentation: Regulation of software, including software as a med...
 
MDD 93/42/EEC
MDD 93/42/EECMDD 93/42/EEC
MDD 93/42/EEC
 

More from TGA Australia

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
TGA Australia
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
TGA Australia
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
TGA Australia
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
TGA Australia
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
TGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
TGA Australia
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
TGA Australia
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
TGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
TGA Australia
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
TGA Australia
 

More from TGA Australia (20)

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
 
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & APresentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Software as a Medical Device: Regulatory insights and Q & A
 

Recently uploaded

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 

Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for ARTG inclusion

  • 1.
  • 2. Medical devices (IVD) – application process Session Chair ― Wendy-Jane Morrow Chief Executive Officer, IVD Australia Speakers / Panelists ― Euan Miller Assistant Director, Therapeutic Goods Administration Chris Harwood Assistant Director, Therapeutic Goods Administration Karen MacLeod Business Manager, Diagnostics, MP Biomedicals Australasia Pty Ltd
  • 3. Medical Devices (IVDs) Applications for ARTG inclusion Euan Miller Application and Verification Section Medical Devices Branch Devices Sponsor Information Day 15 October 2015
  • 4. Purpose Facilitate better understanding of the regulatory requirements for IVD medical devices ARTG inclusion – explain the process and give some examples
  • 5. What is a medical device? • Used for human beings • Intended purpose – Diagnose, prevent, monitor, treat or alleviate disease or compensate for injury or disability – Investigation, replacement or modification of anatomy or physiological processes – Control conception – Accessory to a medical device as described above • Is to be ascertained from the information provided on or in any one or more of the following: - Labelling - Instructions for use - Any manufacturer’s advertising material relating to the product - Technical documentation Therapeutic Goods Act 1989, section 41BD
  • 6. In vitro diagnostic (IVD) medical device • A reagent, calibrator, control material, kit, specimen receptacle, instrument, software, equipment or system • Intended for the in vitro examination of human specimens for - giving information about a physiological or pathological state - giving information about a congenital abnormality - determining safety and compatibility with a potential recipient - monitoring therapeutic measures Dictionary, Therapeutic Goods (Medical Devices) Regulations 2002
  • 8. Types of IVD medical devices • Intended to be used by: – health professionals in the laboratory – health professionals at the point of care – lay-person (self-testing) • Does not include Research Use Only (RUO) or Analyte Specific Reagents (ASR)
  • 9. ARTG inclusion • Any IVD medical device must be included in ARTG - Transitional provisions ended on 30 June 2015 • Except: - Devices for which effective applications for inclusion in the ARTG were submitted before the end of transitional period but not yet finalised - In-house IVD medical devices (transitional provisions until 30 June 2017) • Sponsor is responsible for ARTG inclusion
  • 10. Before you start • TGA Business Services (TBS) - Register and get your Client ID
  • 11. Important Classification based on the intended purpose and level of risk of the device Conformity assessment procedures Essential principles for safety and performance Post-market monitoring
  • 12. Process for ARTG inclusion
  • 13. Manufacturer Evidence • Manufacturer must apply appropriate conformity assessment procedure to the device (quality management system and control over the design of the device) • Sponsor must lodge the manufacturer’s certification of the conformity assessment with the TGA - Except for Class 1 IVD Acceptable certificates - TGA conformity assessment certificate - EC Certificate issued in accordance with IVDD 98/79/EC - ISO 13485 (CMDCAS ISO 13485 or IAF ISO 13485)
  • 14. Manufacturer Evidence  ACCEPTED −What does it mean? Go to the next step - lodging application for ARTG inclusion
  • 15. Application for ARTG inclusion • Must be made for a kind of device and • Must be effective - Made in accordance with a form and manner approved (via TBS) - Application fee is paid - For Class 4 IVD – conformity assessment certificate must be issued by the TGA for the device - Must not contain information that is false or misleading in a material particular
  • 16. Matters certified must be correct medical device intended purpose correctly classified essential principles and availability of information to substantiate compliance application of conformity assessment procedure and availability of information requirements (if any) relating to advertising prohibited imports excluded purposes information in or with the application is complete and correct Therapeutic Goods Act 1989, section 41FD
  • 17. Common questions Kind of device Intended purpose Classification Conformity assessment procedure GMDN code
  • 18. Kind of device • Sponsor • Manufacturer • Device nomenclature system code (GMDN) • Classification • Unique product identifier (for Class 4 IVDs) a medical device is taken to be of the same kind as another medical device if they have the same: Therapeutic Goods Act 1989, section 41BE and Therapeutic Goods (Medical Devices) Regulations 2002, regulations 1.6 and 1.7
  • 19. Examples of the kinds of devices • Blood glucose monitoring system (BGMS) (including strips) AND test strips AND controls  These devices are of the same kind • BGMS (excluding strips) AND test strips AND controls X These devices are not of the same kind
  • 20. Intended purpose of a kind of device • Means the purpose for which the manufacturer of the device intends it to be used, as stated in the information provided with the device (labeling, instructions for use, advertising material and technical documentation) • Intended purpose stated in the application must be consistent with the purpose for which the manufacturer intends the devices of the kind to be used - specific versus general - 500 characters only (in the application)
  • 21. IVD medical devices are classified having regard to the intended purpose of the device and its risk to public health and/or personal risk RISK • Class 1 IVD – no public health risk or low personal risk • Class 2 IVD – low public health risk or moderate personal risk • Class 3 IVD – moderate public health risk or high personal risk • Class 4 IVD – high public health risk Therapeutic Goods (Medical Devices) Regulations 2002, division 3.1 and schedule 2A
  • 22. Classification (Schedule 2A) Rule 1.1 Class 4 Rule 1.2 Class 3 /4 Rule 1.3 Class 3 Rule 1.4 self- testing Rule 1.5 QC Rule 1.6 Class 1 Rule 1.7 Class 2 Rule 1.8 Class 1 Export only
  • 23. Classification examples • Class 1 IVDs - Microbiological culture media; instruments/analysers • Class 2 IVDs - Pregnancy self-tests, H&E stain • Class 3 IVDs - sexually transmitted diseases; genetic tests (inc. FISH) • Class 4 IVDs - screen blood donors for HIV & HCV; ABO
  • 24. Common questions • Pathogens listed on the Australian National Notifiable Disease Surveillance System (NNDSS) list • Human genetic testing • Patient selection* for: i. selective therapy and management ii. disease staging iii. diagnosis of cancer *An IVD medical device would fall into Class 2 IVD if a) a therapy decision would usually be made only after further investigation; or b) the device is used for monitoring
  • 25. Conformity assessment procedure Declaration of conformity - To be provided with the application:  Class 3 IVDs - Must be made in accordance with Schedule 3 of the Therapeutic Goods (Medical Devices) Regulations 2002 - Must contain correct information (including Certificate number appropriate for the device) - Templates available
  • 26. Global Medical Device Nomenclature (GMDN) • GMDN code - one of the characteristics that defines the kind of device - is to be consistent with the intended purpose of the device • Depends on Class of IVD device - relevant preferred term or - Level 1, Level 2 or Level 3 collective term (CT) Manufacturer’s responsibility
  • 27. GMDN examples IVD medical device GMDN HIV1/HIV2 antigen IVD, kit, immunochromatographic test (ICT) rapid [30832] Human immunodeficiency viruses (HIV) [CT284] Viral Infectious disease IVDs [CT355] Infectious disease IVDs [CT701]
  • 28. GMDN – more examples IVD medical device GMDN Multiple urine analyte IVD, kit, colourimetric dipstick, rapid [30225] Urine screening IVDs [CT1246] Clinical chemistry biological screening IVDs [CT1236] Clinical chemistry IVDs [CT287]
  • 29. GMDN – one more example IVD medical device GMDN Glucose monitoring system IVD, home use/point-of-care [30854] No relevant level 3 Collective Term (CT) Clinical chemistry substrate IVDs [CT833] Clinical chemistry IVDs [CT287]
  • 30. IVD Name and Category For any type of IVD device referred to in Regulation 5.3(1)(j), the application form requires applicants to enter the names of all individual devices of the kind as these devices appear on the labelling.
  • 31. Procedure Packs containing IVD • Goods in the package are a system or procedure pack if - the goods are for use as a unit, either in combination or in a medical or surgical procedure and - the package contains at least one medical device • Classification - is determined by the highest class of device included in the pack or - if all devices are of the same class, it is classified according to the primary intended purpose of the system or procedure pack
  • 32. Procedure packs Reg. 3.3 (9) – highest classification IVD (Class 3) MD (Class IIa) Class 3 IVD Procedure Pack
  • 33. Procedure packs Reg. 3.3 (10) same class IVD (Class 1) MD (Class I) Class 1 IVD or Class I MD Procedure Pack Intended purpose
  • 34. One kind of device Supplied as a SINGLE unit Instrument Control/CalibratorsAssay Kit
  • 35. Devices are not of the same kind System Instrument (Class 1 IVD) Controls / Calibrators Assay Kit Accessories
  • 36. Where do we go from here? Ensure all information provided in the application is correct Any application may be selected for audit Some applications must be selected for audit
  • 37. Further information • IVD medical devices regulation basics • News, consultations, guidance, subscribe to updates TGA website • Therapeutic Goods Act 1989, Chapter 4 • Therapeutic Goods (Medical Devices) Regulations 2002 ComLaw: Database of Commonwealth law • devices@tga.gov.au 1800 141 144 Contact the TGA Medical Devices Branch
  • 38.
  • 39. The Application Process • Introduction • This presentation will step through the process of making an application for inclusion on the ARTG • The format is screen shots highlighting the key steps • Two scenarios will be presented • An uncomplicated Class2 IVD • A Class 3 IVD requiring higher level scrutiny
  • 40. The Application Process • Before you start • The appropriate Manufacturer’s Evidence for your IVD must be submitted and accepted. • Know the Class of your IVD. • Know the GMDN term for your IVD. • Have at hand any other evidence that will be required, such as • Declaration of Conformity (for all Class 3) • Design Examination Certificate (for all Class 4)
  • 42.
  • 43.
  • 44. Navigation buttons top and bottom on each page
  • 45.
  • 47.
  • 48.
  • 49. The Application Process Scenario 1 • Class 2 • Manufacturer Evidence CMDCAS ISO 13485 Certificate • “No” to device product characteristics questions
  • 50.
  • 51.
  • 52. The Application Process Scenario 2 • Class 3 • Manufacturer Evidence TGA Conformity Assessment Certificate • “Yes” to device product characteristics questions • Testing for a sexually transmitted agent
  • 53.
  • 54. TGA Conformity Assessment Certificate = the application is unlikely to be selected for audit
  • 55. The Application Process GMDN selection • The same for either scenario
  • 56.
  • 57.
  • 58. The Application Process Finalisation Class 2 • Make the declaration, Validate and submit
  • 59.
  • 60. The Application Process Finalisation Class 3 • Declaration of Conformity to be attached
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.

Editor's Notes

  1. 16
  2. 17
  3. 23
  4. 24
  5. 35
  6. 40
  7. 41
  8. 42
  9. 43
  10. 44
  11. 45
  12. 46
  13. 47
  14. 49
  15. 52
  16. 53
  17. 55
  18. 56
  19. 58
  20. 60
  21. 61
  22. 63